Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

16.7%

3 terminated out of 18 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

44%

4 of 9 completed with results

Key Signals

4 with results75% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (3)
P 1 (2)
P 2 (4)
P 4 (2)

Trial Status

Completed9
Recruiting3
Terminated3
Unknown2
Not Yet Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT06688422Not ApplicableRecruiting

Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy

NCT06860542Phase 2RecruitingPrimary

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

NCT05455034Phase 1RecruitingPrimary

Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis

NCT04590547Phase 2CompletedPrimary

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

NCT04370834Phase 2Terminated

Tocilizumab for Patients With Cancer and COVID-19 Disease

NCT06670872Not Yet RecruitingPrimary

A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia

NCT04040244Not ApplicableTerminatedPrimary

Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis

NCT03962725Phase 4Terminated

Avoiding Neuromuscular Blockers to Reduce Complications

NCT04721444Completed

Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)

NCT05280873Phase 1UnknownPrimary

Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP

NCT02788643Completed

Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies

NCT03012958Completed

Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease

NCT03730428Completed

Everolimus Related Pneumonitis in MBC

NCT04326725UnknownPrimary

Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia

NCT04302688CompletedPrimary

Accurate Classification System for Patients With COVID-19 Pneumonitis

NCT02246361Phase 4Completed

Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication

NCT00997555Not ApplicableCompleted

Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients

NCT00081315Phase 2Completed

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Showing all 18 trials

Research Network

Activity Timeline